Drug discovery timelines remain a major challenge, particularly in the early stages where assay design is critical to project success. Traditionally, assay development has depended heavily on expert judgment, trial-and-error methods, and labor-intensive manual work, making the process slow, costly, and unpredictable. These limitations often lead to higher expenses and delayed milestones. Advances in data analytics and artificial intelligence are transforming this landscape by enabling intelligent, data-driven assay design. AI-powered approaches improve repeatability, reduce cycle times, and enhance precision, allowing researchers to make more strategic decisions and accelerate early discovery while improving overall reliability and efficiency.

Join for free to read